AGEN trade ideas
AGEN: Bullish PennantBullish Pennant
Descending volume during formation
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 5
200MA ascending
250RSI above 50
PT = 7.32$
$AGENWedge breakout setup with inverse head and shoulders wouldnt mind seeing if it bounces off the 100ma again for a dip buy
agen breaking out of downward trend looking at 2 potential targeCheck the chart. Like, follow, and enjoy! Cheers!
AGEN - Easy Long from HereI have been closely following AGEN after their approval of the Shingrix Vaccine. After a couple years of shortage issues, sales this year should be killer (they are partnered with GSK). Look for more positive news to come in about their oncology pipeline as well.
Weekly MACD cross, volume picking up. 1st target 5.00, selling part of my position there and holding the rest until spring.
$AGEN - 2 scenarios around 3.9$1. Keeping above 3.9 and potential entry for target 4.5.
2. Breaking below, and the bottom channel can be tested.
Not for any advise
Just an Idea.
$AGEN - 4.5-4.4 is the main area of support Very nice channel with positive slope.
Not for any advise
Just an Idea.
AGEN: ready to launchAGEN has retraced 61.8% of the first impulse leg higher and is ready to rally again.
AGEN: Ascending Triangle, Waiting for confirmationAscending Triangle, waiting for confirmation
Pros:
Descending volume during formaiton
Volume on break out
PPS above 50MA and 200MA
250RSI above 50
RS above 0 and climbing
200MA flat/climbing
ATR climbing, more volatile
If confirmed:
PT = 7,25$
$AGEN can rise in the next daysContextual immersion trading strategy idea.
Agenus Inc., a clinical-stage immuno-oncology company, engages in advancing a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer.
The demand for shares of the company still looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $4,18;
stop-loss — $3,95.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$AGEN Possible C&H breakout Agenus (NASDAQ:AGEN) inks an agreement with Hangzhou-based Betta Pharmaceuticals for the development and commercialization of PD-1 inhibitor balstilimab and CTLA-4 inhibitor zalifrelimab in Greater China, including the mainland, Hong Kong, Macau and Taiwan.
Under the terms of the deal, AGEN will receive $15M in upfront cash plus a $20M equity investment, up to $100M in milestones and royalties on net sales. Betta will have exclusive rights to both drugs either as monotherapies or in combination, exclusive of intravesical (drug administered directly into the bladder) delivery.
AGEN - See Past Post - This ride isn't overAll,
See my previous post on my baby aka favorite stock. My entry was $2.28 on this. There pipeline was epic, FDA approvals and no price movement. Now it just hit every scanner and radar out there. I would not buy in now of course, but over time it will come back and retest the last high it left from. It may happen quickly but I would put my alert around 50% of the big bar. I will update later on re buy ins for this stock.
Reached tuesdays 2nd target of 4. But back to Mondays price.It got there, but couldn't hang. Hopefully tomorrow will be the tell all at the end bell. If not to Wednesdays target, im out LOL.
AGEN gets approval from FDA 5-14Thinking it was gonna go north today ? No such luck.
I believe Monday will be the kickstart that's needed to begin its run for the short. Climbing on Monday over the the 2.50s, only to come back to the high to mid 2.40s. Then the next two days, Tuesday and Wednesday, will be good gain days, full bullish days and maybe Friday as well. Fundamentals are primed and Techs look good as well. Hoping for a public announcements from " The Company" this coming week ? Will there be ? Not that I've heard or researched as of yet, NO. But ill update if there is one.
Mondays target reached !! Will it go higherPresentation on May 29th for the American cancer society may help...
AGEN - Add to watchlist ASAP.Read the news on last two AGEN articles.. approved for FDA and beat the EPS... This is a monthly chart and i can at LEAST see x2 profits ahead.
Blackrock own this , should you follow ?IF A is famous and well known in the financial industry, they must know more than me. So following them is safe.
Could this sentence above be true ? YES AND NO.
A good example would be Jim Rogers has been asking or rather influencing people to buy sugar (he likes to carry sugar ratchets in his pocket during interviews) and say how bad agriculture market is , how old the farmers are in different countries , blah blah blah.........
Those who followed his call blindly say 3 years ago would have suffered a loss but those who bought recently , say 2019 would make some tidy profits.
The challenge is Jim is a billionaire and he has the holding power , able to sustain paper losses for years without compromising his lifestyle.
For most retail investors, a 10 -20% drop would likely caused insomnia, stress and inability to focus at work and family. So , we can't compare with the big boys with deep pockets.
However, on this Agenus chart, it appears there is a possibility of it going higher this year.
First thing first, it is supported at 1.58 which is the beginning of the trend reversal. Then , at 2.46 was the next level of support and buying opportunity. It hovers for nearly six months before it charge up and break the 3 dollar mark.
In mid Nov last year, it broke the bearish trend line and has a nice pull back at 3.50 and we are now at 3.85.
I expect the price to continue this bullish move towards 4.80. If it breaks above and closed above it, then we can see it revisiting the 6 dollar mark.
